A few years ago, a group of cancer doctors wanted to open a radiation treatment center in Woodbury. And a rival group wanted to stop them.
Since then, the turf battle has turned into one of the most expensive lobbying campaigns at the Legislature, with one side even outspending Minnesota Vikings lobbyists in 2011.
The two medical groups — Minnesota Oncology and Minneapolis Radiation Oncology (MRO) — have spent millions of dollars on dueling lobbyists since 2007, when the Legislature imposed a moratorium on new radiation treatment facilities in 14 counties, including the Twin Cities and Duluth metro areas.
This year, the Legislature is considering extending the moratorium, said to be the only one in the country, through 2020.
"The amount of money that's being spent is breathtaking," admits Dr. Thomas Flynn, president of Minnesota Oncology, which has 58 physicians. "My personal view is that it's not something that we should be spending time and money on. [But] we've had to have a voice there, because we feel it's an important issue."
Minnesota Oncology, which had hoped to build the Woodbury center, has spent about $1 million to try to overturn the moratorium, so far without luck. MRO, which owns or operates a dozen such facilities at Minnesota hospitals, has spent more than $3 million to keep the moratorium in place.
Each side accuses the other of putting its own financial interests ahead of patients.
The debate touches on a sensitive issue in medicine: Who should control, and profit from, the kind of big-ticket medical technology that requires a huge upfront investment?